MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kokubun, S.
Right arrow Articles by Reuter, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kokubun, S.
Right arrow Articles by Reuter, H.

Studies on Ca channels in intact cardiac cells: voltage-dependent effects and cooperative interactions of dihydropyridine enantiomers

S Kokubun, B Prod'hom, C Becker, H Porzig and H Reuter

We have investigated the effects of two oppositely acting enantiomers of the 1,4-dihydropyridine derivative 202-791 on voltage-dependent Ca channels by combining electrophysiological techniques and binding studies. The (S)-enantiomer of 202-791 promoting prolonged openings of single Ca channels, and thereby increasing transmembrane Ba currents, was classified as channel activator. The (R)-enantiomer favoring a closed state of the channel, and thereby reducing Ba currents, was classified as a channel blocker. Both compounds shifted the steady state current inactivation curve toward more negative potentials. At holding potentials positive to -20 mV, the Ca channel-activating effect of the (S)-enantiomer turned over into a blocking effect. In cells with normal resting potential the combination of the two enantiomers revealed a possible positive cooperative effect resulting in an enhancement of the open state probability of the channels. At depolarized holding potentials the activator enhanced the inhibitory effect of the blocker. Binding studies in intact cells were performed by using the radiolabeled channel-blocking dihydropyridine 3H-(+)-PN 200-110. The results showed a strong increase in binding affinity but no change in binding capacity when the cells were depolarized. Analysis of the interactions of (S)- and (R)-202-791 with this radioligand indicated stimulation of 3H-(+)-PN 200-110 binding by the (S)- enantiomer in polarized cells (membrane potential -38 +/- 4 mV). This effect could be attributed to an increase in binding affinity. The (R)- enantiomer had no such positive cooperative effect, but acted as a purely competitive ligand. Depolarization to 0 mV increased the apparent affinity of both enantiomers by factors of 38 (blocker) and 12 (activator), but abolished the cooperative effect of (S)-202-791 on the binding of the radioligand. Ca ions had little effect on the binding of 3H-(+)-PN 200-110 in polarized cells. However, in the presence of the activating (S)-enantiomer, Ca transformed the usual hyperbolic binding isotherm of the radioligand into a strongly sigmoid curve. Sigmoidicity was minimal with 3-5 microM Ca and maximal with 0.5 mM Ca. Together these data demonstrate homotropic and heterotropic cooperative interactions between channel activator and channel blocker. They indicate that at least two high affinity binding sites for dihydropyridines are associated with voltage-dependent Ca channels. Voltage dependence of both--binding affinity and cooperativity-- suggests that these binding sites are located close to a structural component of the channel which is involved in the potential-sensitive gating process.

Volume 30, Issue 6, pp. 571-584, 12/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Tiwari, Y. Zhang, J. Heller, D. R. Abernethy, and N. M. Soldatov
Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel {alpha}1C subunit
PNAS, November 7, 2006; 103(45): 17024 - 17029.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. Z. Peterson and W. A. Catterall
Allosteric Interactions Required for High-Affinity Binding of Dihydropyridine Antagonists to CaV1.1 Channels Are Modulated by Calcium in the Pore
Mol. Pharmacol., August 1, 2006; 70(2): 667 - 675.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. B. Vieira, C. Kushmerick, M. E. Hildebrand, E. Garcia, A. Stea, M. N. Cordeiro, M. Richardson, M. V. Gomez, and T. P. Snutch
Inhibition of High Voltage-Activated Calcium Channels by Spider Toxin PnTx3-6
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1370 - 1377.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Physiol.Home page
H. Griffiths and K.T. MacLeod
The Voltage-sensitive Release Mechanism of Excitation Contraction Coupling in Rabbit Cardiac Muscle Is Explained by Calcium-induced Calcium Release
J. Gen. Physiol., April 28, 2003; 121(5): 353 - 373.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Erxleben, C. Gomez-Alegria, T. Darden, Y. Mori, L. Birnbaumer, and D. L. Armstrong
Modulation of cardiac CaV1.2 channels by dihydropyridine and phosphatase inhibitor requires Ser-1142 in the domain III pore loop
PNAS, March 4, 2003; 100(5): 2929 - 2934.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Katoh, K. Schlotthauer, and D. M. Bers
Transmission of Information From Cardiac Dihydropyridine Receptor to Ryanodine Receptor : Evidence From BayK 8644 Effects on Resting Ca2+ Sparks
Circ. Res., July 21, 2000; 87(2): 106 - 111.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. J. Salata, N. K. Jurkiewicz, J. Wang, B. E. Evans, H. T. Orme, and M. C. Sanguinetti
A Novel Benzodiazepine that Activates Cardiac Slow Delayed Rectifier K+ Currents
Mol. Pharmacol., July 1, 1998; 54(1): 220 - 230.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Mitra, M. Ugur, O. Ugur, H. M. Goodman, J. R. McCullough, and H. Yamaguchi
(S)-Albuterol Increases Intracellular Free Calcium by Muscarinic Receptor Activation and a Phospholipase C-Dependent Mechanism in Airway Smooth Muscle
Mol. Pharmacol., March 1, 1998; 53(3): 347 - 354.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
L. Chen, N. El-Sherif, and M. Boutjdir
{alpha}1-Adrenergic Activation Inhibits ß-Adrenergic–Stimulated Unitary Ca2+ Currents in Cardiac Ventricular Myocytes
Circ. Res., August 1, 1996; 79(2): 184 - 193.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
N. M. Soldatov, A. Bouron, and H. Reuter
Different Voltage-dependent Inhibition by Dihydropyridines of Human Ca[IMAGE] Channel Splice Variants
J. Biol. Chem., May 5, 1995; 270(18): 10540 - 10543.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B Edmonds, M Klein, N Dale, and E. Kandel
Contributions of two types of calcium channels to synaptic transmission and plasticity
Science, November 23, 1990; 250(4984): 1142 - 1147.
[Abstract] [PDF]


Home page
ScienceHome page
C. Chen, M. Corbley, T. Roberts, and P Hess
Voltage-sensitive calcium channels in normal and transformed 3T3 fibroblasts
Science, February 26, 1988; 239(4843): 1024 - 1026.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics